The 'Timing of Androgen-Deprivation therapy in incurable prostate cancer' protocol (TOAD) where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trial
Gillian M Duchesne, Henry H Woo
BJU International | WILEY | Published : 2014
Related Projects (1)
This work was funded by the National Health and Medical Research Council (NHMRC), a multistate Cancer Council grant, the Royal Australian and New Zealand College of Radiologists (RANZCR) and an educational grant for data management from Mayne Pharma.